Analyst consensus rating
Ginkgo Bioworks Analyst Rating: Underperform
Direct answer
Ginkgo Bioworks's consensus rating is Underperform.
2 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $8.00.
Forecast evidence checked November 14, 2026.
Get free Ginkgo Bioworks email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $9.61
- Average price target
- $8.00
- High price target
- $11.00
- Low price target
- $5.00
- Low target gap
- -48%
- Target upside
- -16.8%
- High target gap
- +14.5%
- Target range width
- 62.4%
- Consensus rating
- Underperform
- Analysts
- 2
- Evidence date
- November 14, 2026
- Valid through
- November 21, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Ginkgo Bioworks?
Ginkgo Bioworks has a verified Underperform consensus. The same dataset has an average price target of $8.00.
How far are Ginkgo Bioworks's low and high targets from the recorded price?
The low target implies -48%, while the high target implies +14.5%.
How many analysts are included in Ginkgo Bioworks's consensus?
The verified consensus includes 2 analysts.
How is Ginkgo Bioworks's target upside or downside calculated?
The average target of $8.00 is divided by the recorded price of $9.61, then one is subtracted to produce -16.8%. This does not guarantee a future return.
When was Ginkgo Bioworks's analyst forecast verified?
The data was verified on 2026-11-14. The dataset is valid through 2026-11-21.